why choose us

First received: July 13, 2023

Clinical Trial: A Single Dose, Phase 1 Study of YH35324 in Patients With Various Allergic Diseases

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Allergic Disease

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-Blind, Placebo/Active Controlled, Single Dose, Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Following Subcutaneous Injections of

Brief Summary: This study aims to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) following a single subcutaneous injection of YH35324 in subjects with various allergic diseases.

Read more